UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017199
Receipt number R000019947
Scientific Title Assessment of Arterial Enothelial Functon by using ASV in Patients with Chronic Heart Failure
Date of disclosure of the study information 2015/04/20
Last modified on 2015/11/25 19:13:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of Arterial Enothelial Functon by using ASV in Patients with Chronic Heart Failure

Acronym

Improving Arterial Endothelial Function by ASV

Scientific Title

Assessment of Arterial Enothelial Functon by using ASV in Patients with Chronic Heart Failure

Scientific Title:Acronym

Improving Arterial Endothelial Function by ASV

Region

Japan


Condition

Condition

Chronic Heart Failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Assessment of arterial endotherial function by using ASV therapy in patients with chronic heart failure

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Assessment of FMD(Flow -Mediated Dilation) in patients with heart failure before and post-3-6 month by using ASV

Key secondary outcomes

Comparison of acute effects on FMD between control and CHF Group by using ASV


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Adaptive servo ventilation was recieved to support spontaneous respiration in patients with heart failure only at study day

Interventions/Control_2

FMD was used for evalating the endothlial function.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

the erolled people who can understand the inormation and explanation from the docotors engaged in the present study
CHF Group
1.Prior hospitalization due to CHF and more than and NYHA2
2.LVEF more than and 45% based on 2D echocardiogram
Control Group
1.NYHA1 or asymptomatic
2.no organic heart disease

Key exclusion criteria

1. those with unconsiousness status
2. those with severe neurological deficits and pulmonary diseases
3. patients who can not perform FMD
4. patients who can not get Informed consent

Target sample size

70


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Tsutsui

Organization

Hokkaido University Graduate School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code


Address

Kita 15, Nishi 7, Kita-ku, Sapporo, Japan

TEL

011-706-6970

Email

htsutsui@med.hokudai.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Mamoru Sakakibara

Organization

Hokkaido University Graduate School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code


Address

Kita 15, Nishi 7, Kita-ku, Sapporo, Japan

TEL

011-706-6973

Homepage URL


Email

mike.s@ninus.ocn.ne.jp


Sponsor or person

Institute

Hokkaido University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Hokkaido University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 04 Month 20 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Though there are no significant change between both groups in endothrlial function by using FMD, brachial artery diameters became more increased in CHF group than Control group.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 07 Month 13 Day

Date of IRB


Anticipated trial start date

2012 Year 08 Month 01 Day

Last follow-up date

2015 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2015 Year 12 Month 30 Day


Other

Other related information



Management information

Registered date

2015 Year 04 Month 20 Day

Last modified on

2015 Year 11 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019947


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name